Zimmer Holdings, Inc. (ZMH)

ZMH (NYSE)
$114.50
neg -1.73
-1.49%
Today's Range: 114.35 - 117.54 | ZMH Avg Daily Volume: 0
Last Update: 01/28/15 - 4:00 PM EST
Volume: 1,587,700
YTD Performance: 0.00%
Open: $116.37
Previous Close: $116.23
52 Week Range: $90.48 - $120.70
Oustanding Shares: 169,354,000
Market Cap: 19,826,272,800
6-Month Chart
TheStreet Ratings Grade for ZMH
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
ZMH Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for ZMH:
EBITDA 0.00B
Revenue 0.00B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.70 $1.52 $6.05 $6.50
Number of Analysts 13 8 17 16
High Estimate $1.71 $1.58 $6.07 $7.55
Low Estimate $1.68 $1.47 $6.03 $6.26
Prior Year $1.66 $1.50 $5.75 $6.05
Growth Rate (Year over Year) 2.64% 1.25% 5.24% 7.39%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bullishZimmer upgraded at JP Morgan

Jan 5, 2015 | 7:16 AM EST

ZMH was upgraded from Neutral to Overweight, JP Morgan said. $136 price target. Management can unlock value, by integrating the Biomet purchase. 

bullishZimmer upgraded at Morgan Stanley

Jan 5, 2015 | 6:39 AM EST

ZMH was upgraded from Equal-weight to Overweight, Morgan Stanley said. $134 price target. Valuation call, as Biomet should help drive growth. 

By

Jim Cramer

 | Dec 22, 2014 | 7:00 AM EST

Throughout this historic run, four groups have consistently led the market.

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

updatePiper Healthcare Conf.

Dec 2, 2014 | 7:42 AM EST

Piper Jaffray Healthcare Conference (Day 1 of 2) - 12/02/14 - 12/03/14 New York City, NY

By

Christopher Versace

 | Oct 25, 2014 | 12:00 PM EDT

Americans are living much longer these days -- and there are a number of ways to invest.

By

David Katz

 | Oct 21, 2014 | 12:30 PM EDT

Investing during a mid-term election can offer large returns.

By

Christopher Versace

 | Sep 18, 2014 | 11:00 AM EDT

Consider this unsexy but good value play in healthcare. 

By

David Katz

 | Sep 12, 2014 | 11:44 AM EDT

 Hepatitis C therapies are the pacesetters.

bullishZimmer upgraded at William Blair

Aug 18, 2014 | 7:22 AM EDT

ZMH was upgraded to Outperform, William Blair said. Recent pullback has created a buying opportunity, as the Biomet deal should be accretive to earnings.

Kulicke & Soffa(+7%)is in full breakout mode today. The stock opened with an ups...
Seemed as if comments related to inflation were a table setter in pushing out the first ra...
While many are concerned about a negative reaction if the Fed doesn't hint at pushing out ...
We are nearly to the Fed decision and this time around expectations for what's to come are...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.